RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kim Kline to Tocopherols

This is a "connection" page, showing publications Kim Kline has written about Tocopherols.
Connection Strength

3.004
  1. Tiwary R, Yu W, Sanders BG, Kline K. a-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73. Breast Cancer Res. 2011 Jan 07; 13(1):R1.
    View in: PubMed
    Score: 0.372
  2. Tiwary R, Yu W, Li J, Park SK, Sanders BG, Kline K. Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis. PLoS One. 2010 Jul 29; 5(7):e11865.
    View in: PubMed
    Score: 0.361
  3. Wang P, Yu W, Hu Z, Jia L, Iyer VR, Sanders BG, Kline K. Involvement of JNK/p73/NOXA in vitamin E analog-induced apoptosis of human breast cancer cells. Mol Carcinog. 2008 Jun; 47(6):436-45.
    View in: PubMed
    Score: 0.310
  4. Jia L, Yu W, Wang P, Sanders BG, Kline K. In vivo and in vitro studies of anticancer actions of alpha-TEA for human prostate cancer cells. Prostate. 2008 Jun 01; 68(8):849-60.
    View in: PubMed
    Score: 0.310
  5. Riedel SB, Fischer SM, Sanders BG, Kline K. Vitamin E analog, alpha-tocopherol ether-linked acetic acid analog, alone and in combination with celecoxib, reduces multiplicity of ultraviolet-induced skin cancers in mice. Anticancer Drugs. 2008 Feb; 19(2):175-81.
    View in: PubMed
    Score: 0.303
  6. Wang P, Jia L, Sanders BG, Kline K. Liposomal or nanoparticle alpha-TEA reduced 66cl-4 murine mammary cancer burden and metastasis. Drug Deliv. 2007 Nov; 14(8):497-505.
    View in: PubMed
    Score: 0.298
  7. Yu W, Jia L, Wang P, Lawson KA, Simmons-Menchaca M, Park SK, Sun L, Sanders BG, Kline K. In vitro and in vivo evaluation of anticancer actions of natural and synthetic vitamin E forms. Mol Nutr Food Res. 2008 Apr; 52(4):447-56.
    View in: PubMed
    Score: 0.077
  8. Snyder RM, Yu W, Jia L, Sanders BG, Kline K. Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth. Nutr Cancer. 2008; 60(3):401-11.
    View in: PubMed
    Score: 0.075
  9. Yu W, Shun MC, Anderson K, Chen H, Sanders BG, Kline K. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells. Apoptosis. 2006 Oct; 11(10):1813-23.
    View in: PubMed
    Score: 0.069
  10. Kline K, Yu W, Sanders BG. Vitamin E and breast cancer. J Nutr. 2004 12; 134(12 Suppl):3458S-3462S.
    View in: PubMed
    Score: 0.061
  11. Zhang S, Lawson KA, Simmons-Menchaca M, Sun L, Sanders BG, Kline K. Vitamin E analog alpha-TEA and celecoxib alone and together reduce human MDA-MB-435-FL-GFP breast cancer burden and metastasis in nude mice. Breast Cancer Res Treat. 2004 Sep; 87(2):111-21.
    View in: PubMed
    Score: 0.060
  12. Anderson K, Simmons-Menchaca M, Lawson KA, Atkinson J, Sanders BG, Kline K. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA. Cancer Res. 2004 Jun 15; 64(12):4263-9.
    View in: PubMed
    Score: 0.059
  13. Shun MC, Yu W, Gapor A, Parsons R, Atkinson J, Sanders BG, Kline K. Pro-apoptotic mechanisms of action of a novel vitamin E analog (alpha-TEA) and a naturally occurring form of vitamin E (delta-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Cancer. 2004; 48(1):95-105.
    View in: PubMed
    Score: 0.057
  14. Yu W, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res. 2003 May 15; 63(10):2483-91.
    View in: PubMed
    Score: 0.055
  15. You H, Yu W, Munoz-Medellin D, Brown PH, Sanders BG, Kline K. Role of extracellular signal-regulated kinase pathway in RRR-alpha-tocopheryl succinate-induced differentiation of human MDA-MB-435 breast cancer cells. Mol Carcinog. 2002 Apr; 33(4):228-36.
    View in: PubMed
    Score: 0.051
  16. Yu W, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1. Nutr Cancer. 2002; 43(2):227-36.
    View in: PubMed
    Score: 0.050
  17. Yu W, Liao QY, Hantash FM, Sanders BG, Kline K. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells. Cancer Res. 2001 Sep 01; 61(17):6569-76.
    View in: PubMed
    Score: 0.049
  18. Yu W, Israel K, Liao QY, Aldaz CM, Sanders BG, Kline K. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer Res. 1999 Feb 15; 59(4):953-61.
    View in: PubMed
    Score: 0.041
  19. Yu W, Simmons-Menchaca M, You H, Brown P, Birrer MJ, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells. Mol Carcinog. 1998 Aug; 22(4):247-57.
    View in: PubMed
    Score: 0.039
  20. Zhao B, Yu W, Qian M, Simmons-Menchaca M, Brown P, Birrer MJ, Sanders BG, Kline K. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells. Mol Carcinog. 1997 Jul; 19(3):180-90.
    View in: PubMed
    Score: 0.036
  21. Yu W, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest. Nutr Cancer. 1997; 27(1):92-101.
    View in: PubMed
    Score: 0.035
  22. Yu W, Heim K, Qian M, Simmons-Menchaca M, Sanders BG, Kline K. Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells. Nutr Cancer. 1997; 27(3):267-78.
    View in: PubMed
    Score: 0.035
  23. Yu W, Sanders BG, Kline K. Modulation of murine EL-4 thymic lymphoma cell proliferation and cytokine production by vitamin E succinate. Nutr Cancer. 1996; 25(2):137-49.
    View in: PubMed
    Score: 0.033
  24. Charpentier A, Simmons-Menchaca M, Yu W, Zhao B, Qian M, Heim K, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells. Nutr Cancer. 1996; 26(2):237-50.
    View in: PubMed
    Score: 0.033
  25. Turley JM, Sanders BG, Kline K. Vitamin E succinate induction of HL-60 cell adhesion: a role for fibronectin and a 72-kDa fibronectin-binding molecule. Nutr Cancer. 1995; 23(1):43-54.
    View in: PubMed
    Score: 0.031
  26. Simmons-Menchaca M, Qian M, Yu W, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate inhibits DNA synthesis and enhances the production and secretion of biologically active transforming growth factor-beta by avian retrovirus-transformed lymphoid cells. Nutr Cancer. 1995; 24(2):171-85.
    View in: PubMed
    Score: 0.031
  27. Charpentier A, Groves S, Simmons-Menchaca M, Turley J, Zhao B, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-beta (TGF-beta) by human breast cancer cells. Nutr Cancer. 1993; 19(3):225-39.
    View in: PubMed
    Score: 0.027
  28. Turley JM, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate modulation of human promyelocytic leukemia (HL-60) cell proliferation and differentiation. Nutr Cancer. 1992; 18(3):201-13.
    View in: PubMed
    Score: 0.025
  29. Kline K, Cochran GS, Sanders BG. Growth-inhibitory effects of vitamin E succinate on retrovirus-transformed tumor cells in vitro. Nutr Cancer. 1990; 14(1):27-41.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support